Vertex Pharmaceuticals is the leader in cystic fibrosis treatment. The company has also expanded into other areas in recent years, winning approval for two new drugs. Vertex is the global leader in ...

Snap is introducing a subscription feature that will allow creators to earn recurring income directly from their most engaged fans, as the social media company works to diversify beyond advertising.

Wagner guided, "We expect full year 2026 total company revenue to be in the range of $12.95 billion to $13.1 billion, representing 8% to 9% growth versus the prior year. This outlook anticipates ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Sales in Snap's fourth quarter rose 10% year over year, while net income was $45.2 million, which was up nearly 400% from the $9.1 million it reported a year ago. The social media company said ...

Snap is finally transitioning from a structurally unprofitable social media platform into a diversified, monetizable ecosystem with multiple high-margin revenue streams and clear operating leverage.

CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the Snapchat logo, the social media application operated by Snap Inc. (NYSE: SNAP), a U.S.-based social media and ...

President Trump signed a bill that made his 2019 tax cuts permanent and cut SNAP funding by an estimated $186 billion through 2034. The new law makes it more difficult to qualify for SNAP benefits by ...

THOUSANDS OF KENTUCKIANS ARE AT RISK OF LOSING THEIR SNAP BENEFITS. THE QUALIFICATIONS FOR SNAP BENEFITS JUST CHANGED OVER THE WEEKEND. AS PART OF THE BIG, BEAUTIFUL BILL THAT WAS SIGNED LAST JULY.